The HPV vaccine was introduced in England in 2008 and initially offered to girls aged 12 and 13 through school-based immunisation programmes. The vaccine protects against high-risk strains of HPV, a virus responsible for nearly all cases of cervical cancer worldwide. According to the World Health Organization, HPV contributes to approximately 99% of cervical cancer cases.